Three-Year Clinical Outcomes of a Thin-Strut Biodegradable-Polymer Everolimus-Eluting Stent in Patients With Acute Coronary Syndrome
暂无分享,去创建一个
Min Chul Kim | M. Jeong | D. Sim | J. Bae | Janghyun Cho | D. Kim | Y. Jeong | M. Yoon | S. U. Lee | K. Hwang | B. Hwang | Y. Hong | Y. Cho | K. Chun | S. Joo | K. Park | J. Heo | Jongseon Park | Soo-Joong Kim | Ju Han Kim | Youngkeun Ahn | Dae Young Hyun | S. H. Kim | H. Lee | H. Kim | J. Hwang | K. Cho | T. Ahn | Jin Man Cho | D. Y. Hyun
[1] Teruo Inoue,et al. Mobilization of progenitor cells and vessel healing after implantation of SYNERGY in acute coronary syndrome , 2021, Scientific Reports.
[2] C. Terkelsen,et al. Everolimus-Eluting Versus Biolimus-Eluting Stents With Biodegradable Polymers in Unselected Patients Undergoing Percutaneous Coronary Intervention: A Randomized Noninferiority Trial With 1-Year Follow-Up (SORT OUT VIII Trial). , 2019, JACC. Cardiovascular interventions.
[3] Jeehoon Kang,et al. The Evolving Concept of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: Focus on Unique Feature of East Asian and “Asian Paradox” , 2018, Korean circulation journal.
[4] S. Buccheri,et al. Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients. , 2017, JACC. Cardiovascular interventions.
[5] C. Varenhorst,et al. Real‐life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[6] S. Bangalore,et al. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents. , 2017, JACC. Cardiovascular interventions.
[7] A. Kaltoft,et al. Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial. , 2014, JACC. Cardiovascular interventions.
[8] J. Fajadet,et al. Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent. , 2012, Journal of the American College of Cardiology.
[9] Michael Joner,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.
[10] K. Yun,et al. Clinical Outcomes Following SYNERGY Stent Implantation in a Prospective All-Comers Registry , 2022, Journal of Cardiovascular Intervention.